Working... Menu

EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01591356
Recruitment Status : Recruiting
First Posted : May 4, 2012
Last Update Posted : May 29, 2019
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 31, 2020
  Estimated Study Completion Date : July 31, 2020